Janet Woodcock, acting FDA commissioner (Greg Nash/Pool via AP Images)
Woodcock defends FDA's response to Omicron before Senate health committee
In what may be Janet Woodcock’s final congressional hearing as the head of the FDA, she once again offered a candid description of the difficulties …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
